UFC: Carls John de Tomas Gets One Year Ban From USADA

0
UFC Carls John de Tomas suspended by USADA
Carls John de Tomas Credit: Twitter/@ufcgoldenboy

USADA continues to sniff out UFC Anti-Doping Policy violators, with Carls John de Tomas being the latest athlete suspended.

UFC bantamweight Carls John de Tomas, who has gone 0-2 in the promotion to date, will be spending the next year on the sidelines. In a press release distributed Monday, the U.S. Anti-Doping Agency (USADA) announced that the fighter had accepted a one year suspension stemming from a failed drug test following UFC Fresno in December.

de Tomas (6-2), of Quezon City, Philippines, was flagged based off an in-competition urine sample that tested positive for Furosemide, a diuretic (and ergo possible masking agent).

Monday’s press release from USADA added that the test was administered “December 8, 2017, before his bout at the UFC Fight Night event in Fresno, Calif. Furosemide is a Specified Substance in the class of Diuretics and Masking Agents and prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency Prohibited List.” It continued, saying

De Tomas’ one-year period of ineligibility began on December 29, 2017, the date his provisional suspension was imposed. The athlete’s positive test also falls under the jurisdiction of the California State Athletic Commission, which has also sanctioned De Tomas with a one-year suspension and a $2,500 fine.

Pursuant to the UFC Anti-Doping Policy, all UFC athletes serving a period of ineligibility for an anti-doping policy violation are required to continue to make themselves available for testing in order to receive credit for time completed under their sanction.

Prior to joining the UFC in 2017, ‘Golden Boy’ was a perfect 6-0 with all his pro bouts coming in the Philippines’ URCC promotion. Upon reaching the big show, however, he dropped a decision to Naoiki Inoue, and was subsequently submitted by Alex Perez at UFC Fresno.

LEAVE A REPLY

Please enter your comment!
Please enter your name here